Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ENCAPSULATION OF PANCREATIC CELLS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS
Document Type and Number:
Japanese Patent JP2021004258
Kind Code:
A
Abstract:
To provide encapsulation of cells derived from human embryonic stem cells and other pluripotent human cells.SOLUTION: According to the present invention, there is provided a method for producing insulin in vivo in a mammal, the method comprising: (a) providing an in vitro human PDX1-positive pancreatic progenitor cell population into an implantable semi-permeable device; (b) implanting the device with the cell progenitor cell population into a mammalian host; and (c) maturing the progenitor cell population in the device in vivo such that the progenitor cell population comprises endocrine and acinar cells. Here, at least some of the endocrine cells are insulin secreting cells that produce insulin in response to glucose stimulation in vivo, thereby producing insulin in vivo to the mammal.SELECTED DRAWING: Figure 1

Inventors:
LAURA MARTINSON
CHAD GREEN
EVERT KROON
AGULNICK ALAN
OLIVIA KELLY
EMMANUEL E BAETGE
Application Number:
JP2020170889A
Publication Date:
January 14, 2021
Filing Date:
October 09, 2020
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
VIACYTE INC
International Classes:
A61K35/39; A61K9/52; A61K47/10; A61P3/10; A61K35/12
Domestic Patent References:
JP2008538276A2008-10-23
Foreign References:
US20050191282A12005-09-01
US6365385B12002-04-02
WO2007141657A22007-12-13
Other References:
NATURE BIOTECHNOLOGY, vol. 26, JPN6017010230, 2008, pages 443 - 452, ISSN: 0004618255
Attorney, Agent or Firm:
Yoshiyuki Kawaguchi